We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
10:00 AM
-
Imperial Ballroom50 minsWith bank failures and volatile markets this year, it is more important than ever for early-stage companies to demonstrate their distinct strengths as investors evaluate their priorities. Attend this ...
11:00 AM
-
Imperial Ballroom50 minsThe ability of bispecific antibodies and antibody drug conjugates to interact with two biologic binding sites at once creates major leverage for interfering with a disease mechanism intercellularly as ...
1:00 PM
-
240 minsAttend 13-minute presentations across several therapeutic areas.
-
60 minsMore than 130 human health companies are in SOSV's portfolio, and more than 30 of those are pre-series-A biopharma start-ups in IndieBio's program. Mohan Iyer is a General Partner at SOSV’s IndieBio S ...
2:00 PM
-
Imperial Ballroom50 minsWith the majority of biological studies conducted in academic settings but nearly all innovative new drug clinical trials sponsored by industry, improving translational research success rates for comm ...
3:00 PM
-
50 minsWithin the past five years, RNA technologies have demonstrated they can improve patients’ health by transforming gene expression and open a successful new frontier for infectious disease vaccine devel ...
4:00 PM
-
50 minsA recent article noted that the APAC biotech market is estimated to expand at a rapid compound annual growth rate of 16.8 percent up to 2028. With some of the world’s most populous countries, the need ...
9:00 AM
-
180 minsAttend 13-minute presentations across several therapeutic areas.
10:00 AM
-
50 minsSince the passage of the Inflation Reduction Act, companies, investors, and patients have raised concerns about how the legislation will impact innovation in the biotech industry. Will there be a decl ...Moderator
11:00 AM
-
50 minsA Nature biotechnology report cited an analysis of the 25 most active VC firms that shows less than 1% of senior level investment teams have partners from underrepresented racial and ethnic groups. Mc ...
12:00 PM
-
50 minsDr. Julia Owens is an experienced biopharmaceutical CEO and board member with a deep commitment to advancing innovative therapies for patients over a 20+ year professional career. She brings a unique ...
1:00 PM
-
240 minsAttend 13-minute presentations across several therapeutic areas.
-
Imperial Ballroom50 minsRelative to other highly prevalent diseases such as cancers or cardiovascular disease, companies seeking therapies for neurodegeneration have struggled with drug delivery and biomarker validation insi ...
2:00 PM
-
Imperial Ballroom50 minsLast year, Google’s AlphaFold project demonstrated it can model more than 200 million molecular 3-D structures, including nearly all known proteins, by applying computational biology and artificial in ...
3:00 PM
-
50 minsAfter an 80% decline in IPO volume from the 2021 peak and the Federal Reserve’s start of raising interest rates, conditions appear now to be shifting towards stabilizing rates and slowly opening the I ...Speakers
)
)
){kind=logo}
)
)
)
)